logo
How to be more intelligent in 2025

How to be more intelligent in 2025

Yahoo29-01-2025

Our culture places a massive premium on our ability to think and solve problems. It influences our career, dating, and overall life outcomes. We've been sold this broken idea that the cards we get are the cards we get. What if intelligence isn't just about genetics, but habits?
You can improve your cognitive skills with a several brain training techniques that will improve your mental performance over time.
Here are six quick strategies that only require 15 minutes a day.
Choose knowledge over test scores
I'll let you in on a little secret: You can improve your IQ score. Just take more IQ tests.
Advertisement
Scores are proven to increase via the Practice Effect. But that doesn't do much for you, does it? In fact, those enhanced scores are considered an error variance (faulty data) by IQ test administrators.
It's easy to get lost in the noise, debate, and hype around intelligence. It's best to think of intelligence as what you do rather than what you are. For example, if you wanted to improve your trivia skills, you wouldn't sit around studying IQ test questions. You'd study random trivia.
The best strategy is to develop a growth mindset and implement continuous learning, which is fueled by curiosity. Expand your knowledge base and information at your disposal.
Many people you perceive as being extremely smart, aren't born geniuses. They are just well-read. They use their time to find, learn and study things that interest them. Even if you only have 15 minutes a day, spending that time reading not only helps you build your knowledge, it activates neural pathways in the brain.
Advertisement
I've never met a unintelligent person who spends their free time reading. Or perhaps I have. But, because they read, they did a good job of hiding it.
Practice problem solving and critical thinking
Studies have repeatedly proven the importance of mental activity and aging. The problem is that most of us get jobs with deep and narrow focuses or which require droning activities, leaving other parts of our brains unchallenged.
For example, there's a game that may actually make you smarter. It's called Dual N-Back Online. It has been shown to reduce dementia in patients.
While most of you don't need to worry about that now, none of you are getting any younger. Contrary to my own skeptical assumptions, scientists also found that brain games, such as Lumosity, boost cognitive function.
Advertisement
Participants demonstrated greater problem-solving and an improved ability to quickly switch between tasks.
Many games are designed specifically for things you struggle with — such as cognition, pattern recognition, memory, and spatial reasoning. Just as some physical exercises boost functional strength, brain games help with real-life cognitive tasks. It spares you from the abstractness of IQ tests.
Remember: Mental exercises don't just improve the mind — they also protect brain health.
A quick and easy creativity drill
Here's a great creativity exercise my writing mentor taught me.
It's simple and you can do it while brushing your teeth. The goal is to think of two things that are as far removed from each other as possible. You could start simple and say, 'Blue and red.' Then you could say, 'Grass and astronomy.'
Advertisement
You work your way out from there. For example, you could think bike, snail, love, stenography, sales, alphabet. Then, in the final step, after you think of the two most radically different subjects — try to connect them.
As a simple example, we could try to connect 'snail' and 'alphabet'.
Both can spell each other — a snail with its slime, the alphabet with its letters. Both words have the letters 'a' and 'l'. Both can be a good soup. You get the drift.
This exercise develops your ability to connect unrelated subjects. This ability sits at the beating heart of creativity
Slow things down with meditation
I began meditating after after my initial resistance to the activity. After doing it consistently for a few weeks, I felt a fundamental change in my mind. My stress went down and my posture improved.
Advertisement
My mind feels calm. The inner noise dies down. I feel still, focused, and uncluttered. Meditation is proven to boost attention and executive function— that part of your brain enabling you to have more control of your actions, to be more deliberate. Another study found that it improves verbal fluency and cognitive flexibility.
And I get that many people resist this suggestion. Just as my friend raved to me about meditation, I was doing the same last month with my neighbor. We were working on his car and I said, 'Have you tried meditation?'
His face scrunched up, 'No, what is that?'
I explained meditation and he gave me this quizzical look like I was talking about hippie wizardry. He's an older military guy. He isn't keen on this type of stuff. However, his doubt isn't uncommon.
Advertisement
Believe in meditation. The impact is real. It strengthens your mind.
I never do it more than 10 minutes a day and it still pays dividends.
With all of the overstimulating flashing screens and notifications, it's immensely healthy and helpful to slow everything down. Your brain needs it.
Don't shy away from exercise and nutrition
Just as meditation, and slowing our minds down, has this counterintuitively useful impact on cognition, so does exercise. It helps reduce the aging effects on our brain, and fortifies your mind to perform at its best. It is also extremely useful in reducing mental health constraints that can negatively impact cognition, such as depression and anxiety (which can hurt executive function, attention spans, and lower processing speed).
Advertisement
Your brain is a biological organ that is at the mercy of the same chemical forces your other organs are. Don't forget to healthy lifestyle habits to give it the best chance to succeed and perform over time.
This includes a healthy brain diet, with omega-3 fatty acids, nuts, berries, green tea, vitamin B12, and leafy greens. Combine this with proper sleep and stress management, and you'll already be ahead of the pack.
Lastly, practice deliberate learning
One of my close friends is a successful author, who was always an average student in school. In English class, he never got praise from his teacher nor did I seek it. His work was mediocre. You'd have never predicted he'd become an author. I even remember
Yet, today, he is much better than many of those star students, writing books and hit essays.
Advertisement
Why? Because he fell in love with the craft on his own terms years later. He didn't quit. He obsessed over the mechanics, iterated, got feedback, and had the humility to learn at something new. His persistence paid off in huge dividends and I am still in awe of how far he's come.
The bigger point I'm making: humans have a remarkable ability to become highly competent at specific things. And while talent will always play a role, it is curiosity and persistence that unlocks your unexpected potential. Make sure you give yourself time to focus on these skills, without distractions, like your phone, which will interrupt deep focus and periods of quick learning.
There are too many defeatist attitudes floating around, 'I'm no good at that.' Or, 'I'm not smart enough for that.'
You being here — reading in your free time— indicates you're probably smarter than the average dot on a scatter plot.
Advertisement
Put in at least 10–15 minutes a day on that one thing you wish you were better at, and watch the change happen.
Remember, believe in yourself and be persistent. The human brain is a magnificent creation of evolution. Do any of these things for 15 minutes a day, and your mind will be better for it. Treat this as a lifelong learning strategy rather than an instant fix.
Recap for your memory

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor
Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor

Business Wire

timea day ago

  • Business Wire

Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced an agreement to develop and commercialize integrated diabetes solutions that combine Abbott's future dual glucose-ketone sensor with Tandem's innovative insulin delivery systems to provide more options for people to manage their diabetes. The Abbott sensor, currently under development, will combine glucose and ketone sensing technology that aims to help people living with diabetes detect early ketone rise to avoid life-threatening diabetic ketoacidosis. "Integrating our advanced insulin delivery systems with Abbott's future glucose-ketone sensor has the potential to help empower people with diabetes to take faster, more informed action to protect their health and improve outcomes," said John Sheridan, president and chief executive officer. "We are excited to continue our partnership with Abbott and look forward to working with them to bring this new integration to customers in the future." About Tandem Diabetes Care, Inc. Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company's pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ+ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit Follow @TandemDiabetes on Facebook, Instagram, LinkedIn, TikTok, and X. Forward-looking Statements This press release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to, among other things, development plans to integrate Tandem insulin delivery systems with Abbott dual glucose and ketone sensing technology. These forward-looking statements are subject to numerous risks and uncertainties, including risks, for example, that technical challenges, clinical or regulatory hurdles or other factors may prevent or delay integration, as well as other risks identified in our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other documents that we file with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Actual results could differ materially from those anticipated or projected in the forward-looking statements. Tandem undertakes no obligation to update or review any forward-looking statement in this press release because of new information, future events or other factors. ©2025 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, the Tandem logo, Control-IQ+, Tandem Mobi and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries. All third-party marks are the property of their respective owners.

Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025
Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025

Yahoo

time03-04-2025

  • Yahoo

Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025

SAN DIEGO, April 03, 2025--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2025 results after the financial markets close on Wednesday, April 30, 2025. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2025 financial and operating results. A live webcast of the call will be available on Tandem Diabetes Care's Investor Center website located at in the "Events & Presentations" section. To access the call by phone, please use this link ( and you will be provided with dial-in details, including a personal pin. An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care's Investor Center website located at in the "Events & Presentations" section. About Tandem Diabetes Care, Inc. Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company's pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ+ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit Tandem Diabetes Care, the Tandem logo, Control-IQ+, Tandem Mobi and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries. View source version on Contacts Media Contact: 858-366-6900media@ Investor Contact: 858-366-6900IR@ Sign in to access your portfolio

Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States
Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States

Yahoo

time18-03-2025

  • Yahoo

Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States

– Enhanced features extend automated insulin delivery (AID) to people ages 2 years and older with type 1 diabetes and adults with type 2 diabetes – SAN DIEGO, March 18, 2025--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced the United States commercial launch of Control-IQ+ technology, the latest generation of the company's advanced hybrid closed-loop algorithm. Control-IQ+, compatible with both the t:slim X2 insulin pump and Tandem Mobi System, is now available for people with type 1 diabetes ages 2 years and older and adults with type 2 diabetes. Pumps pre-loaded with the updated software are now shipping to new customers, and all eligible, in-warranty Tandem customers will have access to the new features via remote software update free of charge. "These new features allow for even greater levels of personalization and flexibility within our algorithm, while still receiving high marks for ease of use across a diverse population of users," said John Sheridan, president and chief executive officer. "We are proud to offer this life-changing technology to millions more people living with diabetes." New features of the Control-IQ+ algorithm include: Expanded weight (20-440 lbs.) and total daily insulin (5-200 units) parameters to accommodate a wider range of insulin requirements. Enhanced extended bolus up to 8 hours with Control-IQ+ turned on, for better management for meals with delayed glucose rise or prolonged eating. New Temp Basal Rate adjustments allowed when Control-IQ+ is active, to address short-term glucose needs, such as exercise, stress, or illness, while Control-IQ+ is turned on. Control-IQ+ builds on the existing features of Tandem's industry-leading Control-IQ algorithm, which in addition to adjusting insulin every 5 minutes based on predicted glucose values, also uses a unique AutoBolus™ feature that calculates and delivers a correction bolus to help with missed meal boluses. Control-IQ+ is also the only AID algorithm that allows users to program extended boluses of up to 8 hours while automation is active to better manage delayed glucose rises or prolonged eating. "The benefits of AID are proven - better sleep, fewer adverse events and better glucose control - any one of these outcomes can be life changing for children living with diabetes and their families," said Dr. Paul Wadwa, director of the pediatric clinic at the Barbara Davis Center for Diabetes and professor of pediatrics at the University of Colorado School of Medicine. "Control-IQ+ is easy to start, use, and personalize. It's exciting to see continued advancement in the field that allows this technology to impact even more lives." All eligible, in-warranty Tandem users can access the software update for their pump by logging into their Tandem Source account: For more information on getting started with Tandem AID visit: About Tandem Diabetes Care, Inc. Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company's pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ+ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit Follow @TandemDiabetes on Facebook, Instagram, LinkedIn, TikTok, and X. ©2025 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, the Tandem logo, Control-IQ+, Control-IQ, t:slim X2, and Tandem Mobi are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries. All other third-party marks are the property of their respective owners. Forward Looking Statements This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that concern matters that involve risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in the forward-looking statements. These forward-looking statements relate to, among other things, the anticipated timing for the commercial launch of the t:slim X2 pump and the Tandem Mobi system with Control-IQ+ technology and our ability to offer the Control-IQ+ software update for current Tandem pump users. These statements are subject to numerous risks and uncertainties, including our ability to commence commercial scale manufacturing of the Tandem pump with Control-IQ+ technology and the risk that we may encounter other challenges that may delay the commercial launch of Tandem pumps with Control-IQ+ technology, as well as other risks identified in our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, and other documents that we file with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Tandem undertakes no obligation to update or review any forward-looking statement in this press release because of new information, future events or other factors. Important Safety Information RX ONLY. The t:slim X2 pump with interoperable technology (the pump) and Control-IQ+ technology (Control-IQ+) are intended for single patient use. The pump and Control-IQ+ are indicated for use with NovoLog or Humalog U-100 insulin. t:slim X2 insulin pump: The pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater. Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of Type 1 diabetes mellitus in persons 2 years of age and greater and of Type 2 diabetes mellitus in persons 18 years of age and greater. WARNING: Control-IQ+ should not be used in anyone under the age of 2 years old with Type 1 diabetes or under the age of 18 years old with Type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely. Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit for additional important safety information. View source version on Contacts Media Contact: 858-366-6900Media@ Investor Contact: 858-366-6900IR@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store